Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

01 Dec 2020 Evaluate

Glenmark Pharmaceuticals has informed that it has attached media release on 1st December 2020 titled ‘Glenmark Pharmaceuticals receives ANDA tentative approval for Axitinib Tablets, 1 mg and 5 mg’ which is self explanatory.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1787.15
Dr. Reddys Labs. 1350.80
Cipla 1363.85
Lupin 1975.90
Zydus Lifesciences 1216.00
View more..